SkyView Investment Advisors’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

SkyView Investment Advisors’s Portfolio BLACU Stock Details BLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,000	Closed	-$323K	–	522
2023 Q3	$323K	Hold	30,000	–	–	0.13%	211
2023 Q2	$323K	Hold	30,000	–	–	0.08%	302
2023 Q1	$309K	Buy	+30,000	New	+$307K	0.07%	306

Other funds holding BLACU

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SkyView Investment Advisors's BLACU Position: Q4 2023 in Review

SkyView Investment Advisors sold out of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) in Q4 2023, closing a stake of 30,000 shares — an estimated $323K sold.

SkyView Investment Advisors first reported a position in BLACU in Q1 2023 and held it in 3 quarters. The position peaked at $323K in Q3 2023. 2 funds tracked by Wall St. Rank hold BLACU as of Q4 2023.

SkyView Investment Advisors reported no remaining Bellevue Life Sciences Acquisition Corp. Unit position as of Q4 2023 after selling out during the quarter.
SkyView Investment Advisors sold 30,000 Bellevue Life Sciences Acquisition Corp. Unit shares in Q4 2023, an estimated $323K.
SkyView Investment Advisors first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and held it in 3 quarters.
SkyView Investment Advisors's Bellevue Life Sciences Acquisition Corp. Unit position peaked at $323K in Q3 2023.
2 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q4 2023.

Based on SkyView Investment Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.